| Name | Title | Contact Details |
|---|
Naviga Commercial Real Estate is a Mason, OH-based company in the Software and Internet sector.
Glam Media, Inc. is one of the leading companies in Software & Internet industry. Glam Media, Inc. is based in Brisbane, CA. You can find more information on Glam Media, Inc. at www.glam.com
Onyx CenterSource is the world`s leading provider of commission payment processing and recovery solutions for hotels and travel agencies. The company strives to build long-lasting relationships with its partners and is passionate about providing quality customer service, consultative insight and cost-effective solutions. Originating in 1992, the company facilitates in excess of $1.2 billion in payments annually, partnering with more than 60,000 hotels and 200,000 travel booking providers in more than 160 countries around the globe. In addition to its headquarters in Dallas, Onyx CenterSource has regional hubs in Tønsberg, Norway; Seville, Spain; and Manila, Philippines.
Dutchie is an all-in-one technology platform offering a full suite of solutions to simplify operations: Point of Sale, Ecommerce, Payments, and more. It is our mission to provide consumers with safe and easy access and supports the wave of positive societal change that cannabis is bringing to the world.
Cypher Genomics is a leading genome informatics company offering a highly accurate, rapid and robust interpretation software solution for users of human genome sequencing. The proprietary, automated genomic interpretation platform allows clinical laboratories to tune Cypher Genomics' market leading sensitivity and specificity profiles to develop molecular tests for diagnostic and prognostic use, and pharmaceutical companies to discover biomarkers from whole genome sequence data in sample sizes typical of early stage drug development studies. Through Mantis™, the genome interpretation software as a service offering, and Coral™, a biomarker discovery service, Cypher Genomics can improve health care and reduce costs by facilitating improved diagnostic accuracy and earlier interventions, optimizing therapeutic approaches and reducing adverse drug reactions. The gap between the ability to generate whole genome sequences at scale and the primarily manual process of interpretation to date creates a significant unmet need that is well served by the Cypher Genomics solution.